Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Alzheimer's Disease

  Free Subscription

Articles published in J Am Geriatr Soc

Retrieve available abstracts of 93 articles:
HTML format

Single Articles

    February 2024
    Who gets to decide on what it means to have Alzheimer's disease?
    J Am Geriatr Soc. 2024 Feb 12. doi: 10.1111/jgs.18793.

  2. RONCARATI JS, DeVone F, Halladay C, Tsai J, et al
    Risk of dementia among veterans experiencing homelessness and housing instability.
    J Am Geriatr Soc. 2024;72:382-389.
    PubMed     Abstract available

  3. HANSON LC, Wessell K, Meeks N, Bennett AV, et al
    Selecting outcomes for pragmatic clinical trials in dementia care: The IMPACT Collaboratory iLibrary.
    J Am Geriatr Soc. 2024;72:529-535.
    PubMed     Abstract available

    January 2024
  4. LARY CW, Ghatan S, Gerety M, Hinton A, et al
    Bone mineral density and the risk of incident dementia: A meta-analysis.
    J Am Geriatr Soc. 2024;72:194-200.
    PubMed     Abstract available

  5. BENNETT AV, O'Brien K, Moreno M, Lanigan K, et al
    Development of a Lived Experience Panel to inform the design of embedded pragmatic trials of dementia care interventions.
    J Am Geriatr Soc. 2024;72:139-148.
    PubMed     Abstract available

    December 2023
  6. BAYER TA, Jiang L, Kunicki ZJ, Quinn M, et al
    Identifying Alzheimer's disease and related disorders via diagnostic codes in Veterans with heart failure.
    J Am Geriatr Soc. 2023 Dec 7. doi: 10.1111/jgs.18701.

  7. WANG J, Shen JY, Conwell Y, Yu F, et al
    Antipsychotic use among older patients with dementia receiving home health care services: Prevalence, predictors, and outcomes.
    J Am Geriatr Soc. 2023;71:3768-3779.
    PubMed     Abstract available

    November 2023
  8. ZHANG AD, Anderson TS, Hastings SN
    Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008-2023.
    J Am Geriatr Soc. 2023 Nov 2. doi: 10.1111/jgs.18645.

  9. CHIN NA, Widera E, Brangman SA, Karlawish J, et al
    Monoclonal anti-amyloid antibodies for the treatment of Alzheimer's disease and the hesitant geriatrician.
    J Am Geriatr Soc. 2023 Nov 1. doi: 10.1111/jgs.18652.

  10. MALVITZ M, Zahuranec DB, Chang W, Heeringa SG, et al
    Driving predictors in a cohort of cognitively impaired Mexican American and non-Hispanic White individuals.
    J Am Geriatr Soc. 2023;71:3520-3529.
    PubMed     Abstract available

    October 2023
  11. BURKE LG, Burke RC, Duggan CE, Figueroa JF, et al
    Trends in healthy days at home for Medicare beneficiaries using the emergency department.
    J Am Geriatr Soc. 2023;71:3122-3133.
    PubMed     Abstract available

    September 2023
  12. RODRIGUEZ MJ, Kercher VM, Jordan EJ, Savoy A, et al
    Technology caregiver intervention for Alzheimer's disease (I-CARE): Feasibility and preliminary efficacy of brain CareNotes.
    J Am Geriatr Soc. 2023 Sep 14. doi: 10.1111/jgs.18591.
    PubMed     Abstract available

  13. LARGENT EA, Peterson A, Karlawish J
    Supported decision making: Facilitating the self-determination of persons living with Alzheimer's and related diseases.
    J Am Geriatr Soc. 2023 Sep 12. doi: 10.1111/jgs.18596.
    PubMed     Abstract available

    August 2023
  14. HANSON LC, Meeks N, Guo J, Alonzo TRM, et al
    Comfort First: Development and pilot testing of a web-based video training to disseminate Comfort Matters dementia care.
    J Am Geriatr Soc. 2023;71:2564-2570.
    PubMed     Abstract available

    July 2023
  15. ZHANG Y, Luth EA, Phongtankuel V, Ling W, et al
    Factors associated with preventable hospitalizations after hospice live discharge among Medicare patients with Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2023 Jul 7. doi: 10.1111/jgs.18505.

  16. MUTCHIE HL, Orwig DL, Gruber-Baldini AL, Johnson A, et al
    Associations of sex, Alzheimer's disease and related dementias, and days alive and at home among older Medicare beneficiaries recovering from hip fracture.
    J Am Geriatr Soc. 2023 Jul 4. doi: 10.1111/jgs.18492.
    PubMed     Abstract available

    June 2023
  17. BELANGER E, Rosendaal N, Gutman R, Lake D, et al
    Identifying Medicare beneficiaries with Alzheimer's disease and related dementia using home health OASIS assessments.
    J Am Geriatr Soc. 2023 Jun 26. doi: 10.1111/jgs.18487.
    PubMed     Abstract available

    May 2023
  18. TAYLOR B, Barboi C, Boustani M
    Passive digital markers for Alzheimer's disease and other related dementias: A systematic evidence review.
    J Am Geriatr Soc. 2023 May 30. doi: 10.1111/jgs.18426.
    PubMed     Abstract available

    April 2023
    Solitary caregiving in Alzheimer's disease: A slippery slope to abuse.
    J Am Geriatr Soc. 2023 Apr 27. doi: 10.1111/jgs.18385.

  20. STEFANACCI R, Miller S, Loh YS
    Comment on: Effectiveness and safety of anti-tau drugs for Alzheimer's disease.
    J Am Geriatr Soc. 2023 Apr 6. doi: 10.1111/jgs.18351.

  21. ZHENG X, Tang Y, Lu L
    Reply to: Comment on: Effectiveness and safety of anti-tau drugs for Alzheimer's disease.
    J Am Geriatr Soc. 2023 Apr 6. doi: 10.1111/jgs.18352.

  22. COLE CS, Carpenter JS, Blackburn J, Chen CX, et al
    Pain trajectories of nursing home residents.
    J Am Geriatr Soc. 2023;71:1188-1197.
    PubMed     Abstract available

  23. BURGDORF JG, Amjad H
    Impact of diagnosed (vs undiagnosed) dementia on family caregiving experiences.
    J Am Geriatr Soc. 2023;71:1236-1242.
    PubMed     Abstract available

    March 2023
  24. REUBEN DB, Rosenstein HL, Chen K, Pillai A, et al
    A population-based, electronic health record-guided approach to improve the quality of dementia care.
    J Am Geriatr Soc. 2023;71:927-934.
    PubMed     Abstract available

    February 2023
  25. WASTILA L, Qato DM, Fleming S, Johnson A, et al
    Unintended impacts of a national antipsychotic reduction initiative among nursing facility residents with and without Alzheimer's disease.
    J Am Geriatr Soc. 2023 Feb 25. doi: 10.1111/jgs.18276.
    PubMed     Abstract available

    January 2023
  26. CANDON M, Strominger J, Gerlach LB, Maust DT, et al
    Antiepileptic prescribing to persons living with dementia residing in nursing homes: A tale of two indications.
    J Am Geriatr Soc. 2023;71:89-97.
    PubMed     Abstract available

  27. HSHIEH TT, Schmitt EM, Fong TG, Arnold S, et al
    Successful aging after elective surgery II: Study design and methods.
    J Am Geriatr Soc. 2023;71:46-61.
    PubMed     Abstract available

    December 2022
  28. POTTER AJ, Wright B, Akiyama J, Stehlin GG, et al
    Primary care patterns among dual eligibles with Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Dec 31. doi: 10.1111/jgs.18166.
    PubMed     Abstract available

  29. HUA CL, Cornell PY, White EM, Thomas KS, et al
    Injury-related emergency department use among assisted living residents with Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Dec 26. doi: 10.1111/jgs.18207.
    PubMed     Abstract available

    November 2022
  30. KIM H, Senders A, Simeon E, Juarez C, et al
    Use of long-term services and supports among dual-eligible beneficiaries with Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Nov 5. doi: 10.1111/jgs.18115.
    PubMed     Abstract available

  31. LIU R, Ren Y, Hou T, Liang X, et al
    Associations of sleep timing and time in bed with dementia and cognitive decline among Chinese older adults: A cohort study.
    J Am Geriatr Soc. 2022;70:3138-3151.
    PubMed     Abstract available

    October 2022
  32. GILSTRAP L, Cohen A, Ouellet GM, Goyal P, et al
    The association between beta-blockers and outcomes in patients with heart failure and concurrent Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Oct 14. doi: 10.1111/jgs.18086.
    PubMed     Abstract available

  33. ZHENG X, Tang Y, Yang Q, Wang S, et al
    Effectiveness and safety of anti-tau drugs for Alzheimer's disease: Systematic review and meta-analysis.
    J Am Geriatr Soc. 2022 Oct 8. doi: 10.1111/jgs.18025.
    PubMed     Abstract available

  34. DEVI G
    Tolerability and safety with aducanumab in Alzheimer's disease in a community-based setting on a slower titration schedule.
    J Am Geriatr Soc. 2022 Oct 8. doi: 10.1111/jgs.18059.

  35. BAYER TA, DeVone F, McConeghy KW, Halladay CW, et al
    Dementia prevalence, a contextual factor associated with SARS-CoV-2 in veterans affairs community living centers.
    J Am Geriatr Soc. 2022;70:2973-2979.
    PubMed     Abstract available

  36. SHAH SK, Adler RR, Xiang L, Clark CJ, et al
    Patients living with dementia have worse outcomes when undergoing high-risk procedures.
    J Am Geriatr Soc. 2022;70:2838-2846.
    PubMed     Abstract available

    September 2022
  37. REUBEN DB, Evertson LC, Jackson-Stoeckle R, Epstein-Lubow G, et al
    Dissemination of a successful dementia care program: Lessons to facilitate spread of innovations.
    J Am Geriatr Soc. 2022;70:2686-2694.
    PubMed     Abstract available

  38. HOFFMAN GJ, Maust DT, Harris M, Ha J, et al
    Medicare spending associated with a dementia diagnosis among older adults.
    J Am Geriatr Soc. 2022;70:2592-2601.
    PubMed     Abstract available

  39. LEES HAGGERTY K, Campetti R, Stoeckle RJ, Epstein-Lubow G, et al
    Dissemination of a successful dementia care program: Lessons from early adopters.
    J Am Geriatr Soc. 2022;70:2677-2685.
    PubMed     Abstract available

    July 2022
  40. HUNG A, Hall R
    How a Medicare payment model is affecting care for older adults with Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Jul 6. doi: 10.1111/jgs.17948.

    June 2022
  41. KUFFEL RL, Byers AL, Williams B, Fortinsky R, et al
    Prevalence of dementia and mild cognitive impairment before incarceration.
    J Am Geriatr Soc. 2022;70:1792-1799.
    PubMed     Abstract available

  42. DISTEFANO MJ, Alexander GC, Polsky D, Anderson GF, et al
    Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey.
    J Am Geriatr Soc. 2022;70:1685-1694.
    PubMed     Abstract available

    May 2022
  43. HILL JD, Schmucker AM, Siman N, Goldfeld KS, et al
    Emergency and post-emergency care of older adults with Alzheimer's disease/Alzheimer's disease related dementias.
    J Am Geriatr Soc. 2022 May 25. doi: 10.1111/jgs.17833.
    PubMed     Abstract available

  44. SHARMA RK, Teng A, Asirot MG, Taylor JO, et al
    Challenges and opportunities in conducting research with older adults with dementia during COVID-19 and beyond.
    J Am Geriatr Soc. 2022;70:1306-1313.
    PubMed     Abstract available

  45. ONEY M, White L, Coe NB
    Out-of-pocket costs attributable to dementia: A longitudinal analysis.
    J Am Geriatr Soc. 2022;70:1538-1545.
    PubMed     Abstract available

  46. BRIESACHER BA, Olivieri-Mui BL, Koethe B, Saczynski JS, et al
    Psychoactive medication therapy and delirium screening in skilled nursing facilities.
    J Am Geriatr Soc. 2022;70:1517-1524.
    PubMed     Abstract available

    April 2022
  47. MEYERS DJ, Rivera-Hernandez M, Kim D, Keohane LM, et al
    Comparing the care experiences of Medicare Advantage beneficiaries with and without Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Apr 29. doi: 10.1111/jgs.17817.
    PubMed     Abstract available

  48. TAN ZS
    The dawn of disease modification for Alzheimer's disease: Hope and peril.
    J Am Geriatr Soc. 2022 Apr 5. doi: 10.1111/jgs.17774.

  49. MORA PINZON M, Krainer J, LeCaire T, Houston S, et al
    The Wisconsin Alzheimer's Institute Dementia Diagnostic Clinic Network: A community of practice to improve dementia care.
    J Am Geriatr Soc. 2022 Apr 1. doi: 10.1111/jgs.17768.
    PubMed     Abstract available

  50. LU WH, Giudici KV, Guyonnet S, Aggarwal G, et al
    Associations of plasma neurofilament light chain and progranulin with frailty in older adults.
    J Am Geriatr Soc. 2022;70:1236-1243.
    PubMed     Abstract available

    March 2022
  51. DALY T
    The informed majority could help make research into Alzheimer's disease fairer and more efficient.
    J Am Geriatr Soc. 2022 Mar 28. doi: 10.1111/jgs.17756.

  52. DISTEFANO MJ, Alexander GC, Anderson GF
    Reply to: The informed majority could help make research into Alzheimer's disease fairer and more efficient.
    J Am Geriatr Soc. 2022 Mar 28. doi: 10.1111/jgs.17757.

  53. MANEMANN SM, Knopman DS, St Sauver J, Bielinski SJ, et al
    Alzheimer's disease and related dementias and heart failure: A community study.
    J Am Geriatr Soc. 2022 Mar 18. doi: 10.1111/jgs.17752.
    PubMed     Abstract available

    February 2022
  54. BENDER AA, McIntosh RL, Sudduth S, Harris M, et al
    The Georgia Memory Net: Implementation of a statewide program to diagnose and treat Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Feb 8. doi: 10.1111/jgs.17690.
    PubMed     Abstract available

  55. GLYMOUR MM, Mor V
    A Large Pragmatic Trial is the Right Solution for Testing Anti-Amyloid Therapies for Alzheimer's Disease.
    J Am Geriatr Soc. 2022 Feb 6. doi: 10.1111/jgs.17695.

  56. PADOVANI A, Caratozzolo S, Rozzini L, Pilotto A, et al
    "Real-world" eligibility for aducanumab depends on clinical setting and patients' journey.
    J Am Geriatr Soc. 2022;70:626-628.

  57. POLZER ER, Nearing KA, Knoepke CE, Matlock DD, et al
    Firearm access and dementia: A qualitative study of reported behavioral disturbances and responses.
    J Am Geriatr Soc. 2022;70:439-448.
    PubMed     Abstract available

    January 2022
  58. LUNDEBJERG NE, Hollmann PA, Supiano MA
    Of education and public policy: Aducanumab.
    J Am Geriatr Soc. 2022;70:81-84.

    December 2021
  59. SCHULMAN-GREEN D, Hshieh T, Adamis D, Avidan MS, et al
    Domains of delirium severity in Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2021 Dec 24. doi: 10.1111/jgs.17624.
    PubMed     Abstract available

  60. MASURKAR PP, Chatterjee S, Sherer JT, Chen H, et al
    Risk of overactive bladder associated with cholinesterase inhibitors in dementia.
    J Am Geriatr Soc. 2021 Dec 2. doi: 10.1111/jgs.17579.
    PubMed     Abstract available

  61. BORSON S, Chen A, Wang SE, Nguyen HQ, et al
    Patterns of incident dementia codes during the COVID-19 pandemic at an integrated healthcare system.
    J Am Geriatr Soc. 2021;69:3389-3396.
    PubMed     Abstract available

  62. FASHAW-WALTERS SA, McCreedy E, Bynum JPW, Thomas KS, et al
    Disproportionate increases in schizophrenia diagnoses among Black nursing home residents with ADRD.
    J Am Geriatr Soc. 2021;69:3623-3630.
    PubMed     Abstract available

  63. HUNT LJ, Harrison KL, Covinsky KE
    Instead of wasting money on aducanumab, pay for programs proven to help people living with dementia.
    J Am Geriatr Soc. 2021;69:3690-3692.

  64. HOLLISTER BA, Yeh J, Ross L, Schlesinger J, et al
    Building an advocacy model to improve the dementia-capability of health plans in California.
    J Am Geriatr Soc. 2021;69:3641-3649.
    PubMed     Abstract available

  65. WANG J, Cato K, Conwell Y, Yu F, et al
    Pain treatment and functional improvement in home health care: Relationship with dementia.
    J Am Geriatr Soc. 2021;69:3545-3556.
    PubMed     Abstract available

    November 2021
  66. LARGENT EA, Abera M, Harkins K, Feldman SJ, et al
    Family members' perspectives on learning cognitively unimpaired older adults' amyloid-beta PET scan results.
    J Am Geriatr Soc. 2021;69:3203-3211.
    PubMed     Abstract available

    October 2021
  67. DUN C, Walsh CM, Chu NM, McAdams-DeMarco M, et al
    Sleep disorders and the development of Alzheimer's disease among U.S. Medicare beneficiaries.
    J Am Geriatr Soc. 2021 Oct 13. doi: 10.1111/jgs.17498.

  68. CANEVELLI M, Rossi PD, Astrone P, Consorti E, et al
    "Real world" eligibility for aducanumab.
    J Am Geriatr Soc. 2021;69:2995-2998.

    September 2021
  69. HOLLENBECK BK, Dunn RL, Sukul D, Modi PK, et al
    Aortic valve replacement among patients with Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2021 Sep 8. doi: 10.1111/jgs.17432.
    PubMed     Abstract available

  70. ABRAHAM AG, Guo X, Arsiwala LT, Dong Y, et al
    Cognitive decline in older adults: What can we learn from optical coherence tomography (OCT)-based retinal vascular imaging?
    J Am Geriatr Soc. 2021;69:2524-2535.
    PubMed     Abstract available

    August 2021
  71. SHAH SK, Manful A, Reich AJ, Semco RS, et al
    Advance care planning among Medicare beneficiaries with dementia undergoing surgery.
    J Am Geriatr Soc. 2021;69:2273-2281.
    PubMed     Abstract available

  72. LOPEZ RP, McCarthy EP, Mazor KM, Hendricksen M, et al
    ADVANCE: Methodology of a qualitative study.
    J Am Geriatr Soc. 2021;69:2132-2142.
    PubMed     Abstract available

    Shoe ties that bind.
    J Am Geriatr Soc. 2021;69:2348-2349.

  74. HUVENT-GRELLE D, Ficheur G, Beuscart JB, Genin M, et al
    Institutionalization of older French adults with dementia: Role of the informal carer's degree of kinship.
    J Am Geriatr Soc. 2021;69:2290-2297.
    PubMed     Abstract available

    July 2021
  75. ARANDA MP, Kremer IN, Hinton L, Zissimopoulos J, et al
    Impact of dementia: Health disparities, population trends, care interventions, and economic costs.
    J Am Geriatr Soc. 2021;69:1774-1783.
    PubMed     Abstract available

  76. BOUSTANI M, Unutzer J, Leykum LK
    Design, implement, and diffuse scalable and sustainable solutions for dementia care.
    J Am Geriatr Soc. 2021;69:1755-1762.
    PubMed     Abstract available

  77. TEMKIN-GREENER H, Yan D, Wang S, Cai S, et al
    Racial disparity in end-of-life hospitalizations among nursing home residents with dementia.
    J Am Geriatr Soc. 2021;69:1877-1886.
    PubMed     Abstract available

    May 2021
  78. AKUSHEVICH I, Yashkin AP, Yashin AI, Kravchenko J, et al
    Geographic disparities in mortality from Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2021 May 19. doi: 10.1111/jgs.17215.
    PubMed     Abstract available

  79. ERICKSON CM, Chin NA, Coughlin DM, Conway CE, et al
    Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences.
    J Am Geriatr Soc. 2021 May 7. doi: 10.1111/jgs.17184.

  80. BEERI MS, Leugrans SE, Delbono O, Bennett DA, et al
    Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline.
    J Am Geriatr Soc. 2021 May 5. doi: 10.1111/jgs.17206.
    PubMed     Abstract available

    April 2021
  81. LAM S, Lipton RB, Harvey DJ, Zammit AR, et al
    White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    J Am Geriatr Soc. 2021 Apr 23. doi: 10.1111/jgs.17173.
    PubMed     Abstract available

  82. NOEL V, Mouchoux C, Krolak-Salmon P, Novais T, et al
    Evolution in the dispensation of drugs for Alzheimer's disease after removal from the list of reimbursable drugs in France.
    J Am Geriatr Soc. 2021 Apr 5. doi: 10.1111/jgs.17151.

  83. BARDENHEIER BH, Rahman M, Kosar C, Werner RM, et al
    Successful Discharge to Community Gap of FFS Medicare Beneficiaries With and Without ADRD Narrowed.
    J Am Geriatr Soc. 2021;69:972-978.
    PubMed     Abstract available

    March 2021
  84. XU Y, Lavrencic L, Radford K, Booth A, et al
    Systematic review of coexistent epileptic seizures and Alzheimer's disease: Incidence and prevalence.
    J Am Geriatr Soc. 2021 Mar 19. doi: 10.1111/jgs.17101.
    PubMed     Abstract available

  85. WITHERS M, Cortez-Sanchez K, Herrera J, Ringman JM, et al
    "My backpack is so heavy": Experiences of Latino caregivers of family with early-onset Alzheimer's.
    J Am Geriatr Soc. 2021 Mar 13. doi: 10.1111/jgs.17091.
    PubMed     Abstract available

    January 2021
  86. SINGH S, Cocoros NM, Haynes K, Nair VP, et al
    Antidopaminergic-Antiparkinsonian Medication Prescribing Cascade in Persons with Alzheimer's Disease.
    J Am Geriatr Soc. 2021 Jan 11. doi: 10.1111/jgs.17013.
    PubMed     Abstract available

    December 2020
  87. OH ES, Rosenberg PB, Rattinger GB, Stuart EA, et al
    Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD).
    J Am Geriatr Soc. 2020 Dec 31. doi: 10.1111/jgs.16970.
    PubMed     Abstract available

  88. CROSS SH, Warraich HJ
    Rural-Urban Disparities in Mortality from Alzheimer's and Related Dementias in the United States, 1999-2018.
    J Am Geriatr Soc. 2020 Dec 24. doi: 10.1111/jgs.16996.

    November 2020
  89. REUBEN DB, Gill TM, Stevens A, Williamson J, et al
    D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care.
    J Am Geriatr Soc. 2020;68:2492-2499.
    PubMed     Abstract available

  90. MCMASTER M, Kim S, Clare L, Torres SJ, et al
    Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD).
    J Am Geriatr Soc. 2020;68:2629-2637.
    PubMed     Abstract available

  91. JENNINGS LA, Hollands S, Keeler E, Wenger NS, et al
    The Effects of Dementia Care Co-Management on Acute Care, Hospice, and Long-Term Care Utilization.
    J Am Geriatr Soc. 2020;68:2500-2507.
    PubMed     Abstract available

    April 2020
  92. AREVALO SP, Kress J, Rodriguez FS
    Validity of Cognitive Assessment Tools for Older Adult Hispanics: A Systematic Review.
    J Am Geriatr Soc. 2020;68:882-888.
    PubMed     Abstract available

    March 2020
  93. DAVIS KAS, Bishara D, Perera G, Molokhia M, et al
    Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta-Analysis.
    J Am Geriatr Soc. 2020;68:650-658.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.